KAPLAN MATTHEW L. purchased 9.7% of their position (11K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $64.2K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/6/2025ACC: 0001104659-25-107418
+11K
Net shares
Net buyer
$64.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11K
Price / share
$5.84
Trade value
$64.24K
% of position
9.7%
11/5/2025
113.76K→124.76K
Total
Net shares
+11K
Net value
$64.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/5/2025 | P · Purchase | +11K | $5.84 | $64.24K | 9.7% | 113.76K | 124.76K |
| Total | +11K | $64.24K | ||||||
Derivative Transactions0
No derivative transactions reported